Title Category Credit Event date Cost
Acute Myelogenous Leukemia: New Therapies after 40 Years!
  • Transplantation
  • Disease Management
  • Oncology
  • ACPE - Pharmacist
  • ACPE - Pharmacy Technician
  • AMA
  • ANCC
  • Attendance
  • CCMC - General
$0.00 Activity descriptionAML is one of the most aggressive cancers. While other cancers have benefited from new treatments, there has been no encouraging news for most leukemia patients for the past 40 years. With improved biologic understanding of AML and the incorporation of genetic prognostic markers and novel therapeutic options bringing new advancements to the field, individuals with AML have reason to hope. This session will review recent advances and new agents that have been approved for the treatment of AML and discuss the role of biomarkers in AML treatment decisions.
Non-HLA Barriers to Blood/Marrow Transplant
  • Transplantation
  • Disease Management
  • Oncology
  • ACPE - Pharmacist
  • ACPE - Pharmacy Technician
  • AMA
  • ANCC
  • Attendance
  • CCMC - Ethics
$0.00 Activity descriptionHistorically, the lack of finding a human leukocyte antigens (HLA)-match has been perceived as the largest barrier to blood/marrow transplantation (BMT). Many barriers besides a lack of suitably matched donors exist and can have an adverse impact on access and outcomes of BMT. This session will identify key barriers to BMT including barriers that prevent access to care, such as language and cultural differences; illiteracy; and environmental, geographic, genetic, and medical barriers.
CAR T-cell Therapy: A Personalized Immunotherapy Approach to Cancer
  • Disease Management
  • Oncology
  • ACPE - Pharmacist
  • ACPE - Pharmacy Technician
  • AMA
  • ANCC
  • Attendance
  • CCMC - General
$0.00 Activity descriptionWhile chimeric antigen receptor (CAR) T-cell therapy has proven successful in treating certain cancers, severe toxicities have limited its widespread application. This new cancer treatment approach is powerful and does come with serious risks that need to be considered before starting therapy. This session will identify the indications for CAR T-cell therapy and describe the challenges from the toxicities that are unique to CAR T cells. Toxicity management will also be discussed.
Lung-in-a-Box: Advances in Lung Transplant Technology
  • Transplantation
  • ACPE - Pharmacist
  • ACPE - Pharmacy Technician
  • AMA
  • ANCC
  • Attendance
  • CCMC - General
$0.00 Activity descriptionFor individuals with severe lung disease, a lung transplant is an effective treatment. New advances in lung transplant technology have extended the life of a lung once it has been removed from the donor’s body. This session will discuss the advances in lung transplant technology that aim to increase the supply of donor lungs and maximize transplant outcomes.Provided byThis activity is provided by OptumHealth Education.Commercial supportNo commercial support was received for this activity.
Hepatocellular Carcinoma: Treatment Options Outside of Transplant
  • Transplantation
  • Disease Management
  • Oncology
  • ACPE - Pharmacist
  • ACPE - Pharmacy Technician
  • AMA
  • ANCC
  • Attendance
  • CCMC - General
$0.00 Activity descriptionLiver transplantation (LT) is considered the best curative treatment for patients with cirrhosis and hepatocellular carcinoma (HCC) within Milan criteria. Several therapeutic procedures have been proposed as bridging treatments for individuals with HCC awaiting LT. The choice of each treatment is based on: the characteristics of the patient; liver function; comorbidities; and on the number, dimensions, and localization of HCC.
New Allocation Systems and Policy Changes for Liver Transplantation
  • Transplantation
  • ACPE - Pharmacist
  • ACPE - Pharmacy Technician
  • AMA
  • ANCC
  • Attendance
  • CCMC - General
$0.00 Activity descriptionAllocation of liver donor organs in the United States is a complex and evolving process. New allocation/distribution systems are in development that attempt to more accurately allocate organs. This session will address the major paradigm shifts that are underway to improve the equitable allocation of livers for individuals waiting for a liver transplant. Policy changes addressing geographic disparities without compromising outcomes will also be discussed.Provided byThis activity is provided by OptumHealth Education.
Multiple Myeloma: What’s New in Treatment Options
  • Transplantation
  • Disease Management
  • Oncology
  • ACPE - Pharmacist
  • ACPE - Pharmacy Technician
  • AMA
  • ANCC
  • Attendance
  • CCMC - General
$0.00 Activity descriptionOver the past decade, treatment options for multiple myeloma have increased substantially. New treatments have resulted in improved survival rates among individuals with multiple myeloma. A BMT, in combination with high-dose chemotherapy, is a treatment option that offers a chance for durable remission for individuals with multiple myeloma. Treatment goals can vary significantly from person to person and can have a substantial impact on the type(s) and duration of treatment individuals receive.
Colorectal Cancer: Screening Guidelines and Genetic Biomarker Testing
  • Disease Management
  • Oncology
  • ACPE - Pharmacist
  • ACPE - Pharmacy Technician
  • AMA
  • ANCC
  • Attendance
  • CCMC - General
$0.00 Activity descriptionThis activity consists of recorded presentations from the "13th Annual Medical Director/Physician Leadership Forum" held in Austin, Texas, on May 15, 2019.
Chimeric Antigen Receptor (CAR) T-cell Therapy
  • Wellness
  • Transplantation
  • Disease Management
  • Oncology
  • ACPE - Pharmacist
  • ACPE - Pharmacy Technician
  • AMA
  • ANCC
  • Attendance
  • CCMC - General
$0.00 Activity descriptionThis activity consists of recorded presentations from the "13th Annual Medical Director/Physician Leadership Forum" held in Austin, Texas, on May 15, 2019.
Reducing the Clinical and Economic Impact of Diabetes: Translating Evidence-Based Medicine into Clinical Practice
  • Wellness
  • Disease Management
  • Managed care
  • ACPE - Pharmacist
  • ACPE - Pharmacy Technician
  • AMA
  • ANCC
  • Attendance
  • CCMC - General
$0.00 Activity descriptionThis activity consists of recorded presentations from the "13th Annual Medical Director/Physician Leadership Forum" held in Austin, Texas, on May 15, 2019.

Pages